DETERMINATION OF PACLITAXEL IN HUMAN PLASMA BY XLC-MS USING SYMBIOSIS PHARMA

The SymbiosisTM Pharma is Spark Holland's unique solution for integrated on-line SPE-LC-MS automation (XLCMS). The system offers large flexibility in processing different types of samples selecting one of the three fully automated operational modes: LC-MS, XLC-MS, or AMD (Advanced Method Development). A sensitive, specific, accurate and precise assay was developed for the on-line extraction and determination of paclitaxel in human plasma by XLC-MS, using the SymbiosisTM Pharma. This method was developed as part of an evaluation, to introduce this new technology into our bioanalytical laboratory. This application note demonstrates the ease of transfer of an off-line sample pretreatment to an on-line protocol, with a concomitant increase in productivity. Paclitaxel is a taxane diterpene amide that was first extracted from the Western yew, Taxus brevifolia. This compound has been shown to be effective in the treatment of a variety of human neoplastic diseases.

To view the full article please click here


If you have not logged into the website then please enter your details below.



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

 

Today's Picks

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.